Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1957-1968

  Cenci, Elio ^a   Mencacci, Antonella ^a   Del Sero, Giuseppe ^a   Bacci, Angela ^a   Montagnoli, Claudia ^a   D'Ostiani, Cristiana Fè ^a   Mosci, Paolo ^a   Bachmann, Martin ^b   Bistoni, Francesco ^a   Kopf, Manfred ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; FEMALE; HELPER CELL; HOST RESISTANCE; INFECTION SENSITIVITY; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-4; LUNG; LUNG DISEASES, FUNGAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, KNOCKOUT; TH1 CELLS; TH2 CELLS;

EID: 0032750427     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315142     Document Type: Article

References (67)

1. 1. Rhodes JC. Aspergillosis. In: Murphy JW, Friedman H, Bendinelli M, eds. Fungal infections and immune responses. New York: Plenum Press, 1993: 359-77.
2. 2. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis 1991; 13:487-92.
3. 3. Binder RE, Faling LJ, Pugatch RD, Mahasen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61:109-24.
4. 4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26:781-805.
5. 5. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defences against Aspergillus fumigatus. Res Immunol 1998; 149:454-65.
6. 6. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617-31.
7. 7. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease: the importance of the phagocytes in defense against fungi. Am J Med 1981; 71:59-66.
8. 8. Morgenstern DE, Gifford MAC, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-18.
9. 9. Schnaffer A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76:1755-64.
10. 10. Palmer LB, Greenberg HE, Schiff M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991; 46: 15-20.
11. 11. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-51.
12. 12. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:654-62.
13. 13. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993; 167: 905-11.
14. 14. Roilides E, Dimitriadou A, Kadiltsoglou I, et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158:322-9.
15. 15. Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect Dis 1997; 176:1579-83.
16. 16. Wolach B, Alon E, Gottesman G, Yellin A. Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. Clin Infect Dis 1998; 26:204-5.
17. 17. Cenci E, Mencacci A, Fè d'Ostiani C, et al. Cytokine-and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178:1750-60.
18. 18. Romani L. The T cell response against fungal infections. Curr Opin Immunol 1997; 9:484-90.
19. 19. Ryan JJ. Interleukin-4 and its receptor: essential mediators of the allergic response. J Allergy Clin Immunol 1997; 99:1-5.
20. 20. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
21. 21. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183:109-17.
22. 22. Horgan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997; 99:1329-39.
23. 23. Kurup VP, Mauze S, Choi S, Seymour BW, Coffman RB. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 1992; 148:3783-8.
24. + Th2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994; 94:215-21.
25. 25. Crameri R, Faith A, Hemmann S, et al. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996; 184:265-70.
26. 26. Grünig G, Corry DB, Leach MV, Seymour BWP, Kurup VP, Rennick BM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997; 185:1089-99.
27. 27. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245-8.
28. + B-I cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4:15-24.
29. 29. Dalton DK, Pitts MS, Keshaw S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259:1739-42.
30. 30. Cenci E, Perito S, Enssle KH, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997; 65:564-70.
31. 31. Razi-Wolf Z, Galvin F, Gary G, Reiser H. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc Natl Acad Sci USA 1993; 90:11182-6.
32. 32. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993; 262:905-7.
33. + T helper subset selection in mice with candidiasis. J Immunol 1997; 158:2356-62.
34. 34. Mencacci A, Cenci E, Del Sero G, et al. Defective costimulation and impaired Th1 development in TNF/LT-α-double deficient mice infected with Candida albicans. Int Immunol 1998; 10:37-48.
35. 35. Cenci E, Mencacci A, Del Sero G, et al. IFN-γ is required for IL-12 responsiveness in mice with Candida albicans. J Immunol 1998; 161:3543-50.
36. 36. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997; 185:817-24.
37. 37. Cenci E, Mencacci A, Fè d'Ostiani C, et al. Cytokine-and T-helper-dependent immunity in murine aspergillosis. Res Immunol 1998; 149: 445-54.
38. 38. Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococcosis. Res Immunol 1998; 149:387-96.
39. 39. Kolls JK, Nelson S, Summer WR. Recombinant cytokines and pulmonary host defense. Am J Med Sci 1993; 306:330-5.
40. 40. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994; 56:672-86.
41. 41. Wertheim WA, Kunkel SL, Standiford TJ, et al. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol 1993; 151:2166-75.
42. 42. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287-92.
43. 43. Redmond H, Schuchter L, Shou R, et al. Interleukin 4 (IL-4) enhances macrophage microbicidal function. J Leukoc Biol 1990;48(suppl):24.
44. 44. Bobert LA, Waters TA, Pugliese-Sivo CC, Sullivan LM, Narula SK, Grace MJ. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin Exp Immunol 1995; 99: 129-36.
45. + T helper type 1 cell responses to Candida albicans. J Exp Med 1998; 187:307-17.
46. 46. Kurup VP, Guo J, Murali PS, Choi H, Fink JN. Immunopathologic responses to Aspergillus antigen in IL-4 knockout mice. J Lab Clin Med 1997; 130: 567-75.
47. 47. Kurup VP, Choi HY, Murali PS, Xia JQ. Coffman RL, Fink JN. Immune responses to Aspergillus antigen in IL-4 ′ mice and the effect of eosinophil ablation. Allergy 1999; 54:420-7.
48. 48. Kurup VP, Xia JQ, Rickaby BA, Dawson CA, Choi H, Fink JN. Aspergillus fumigatus antigen exposure results in pulmonary lung airway resistance in wild-type but not in IL-4 knockout mice. Clin Immunol 1999; 90: 404-10.
49. 49. Romani L, Bistoni F, Puccetti P. Initiation of T-helper cell immunity to Candida albicans: the role of neutrophils. Chem Immunol 1997; 68:110-35.
50. 50. Kurup VP, Grunig G, Knutsen AP, Murali PS. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 1998; 149:466-77.
51. 51. Mencacci A, Cenci E, Bistoni F, et al. Specific and nonspecific immunity to Candida albicans: a lesson from genetically modified animals. Res Immunol 1998; 149:352-61.
52. 52. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 61:1185-93.
53. 53. Rex JH, Bennet JE, Gallin JI, Malech HL, DeCarlo ES, Melnick DA. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis 1991; 163:849-52.
54. 54. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995; 155:722-9.
55. 55. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997; 159:2858-66.
56. 56. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. IL-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000.
57. 57. Lin JY, Wang Li F, Lin RH. The association between lung innate immunity and differential airway antigen-specific immune responses. Int Immunol 1996; 8(4):499-507.
58. 58. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway responsiveness. J Exp Med 1997; 185:1671-9.
59. 59. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M. B7-CD28/ CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 1997; 158:2042-9.
60. 60. McGuirk P, Mahon BP, Griffin F, Mills KHG. Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol 1998; 28:153-63.
61. 61. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 1994; 152:5723-33.
62. 62. Sethna MP, Parijs LW, Sharpe AH, Abbas AK, Freeman GJ. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1994; 1:415-21.
63. 63. Gause CW, Halvorson MJ, Lu P, et al. The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol Today 1997; 18:115-20.
64. 64. Fallarino F, Fields PE, Gajewski TF. B7-1 engagement of cytotoxicT lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J Exp Med 1998; 188:205-10.
65. 65. Gärdby E, Lane P, Lycke NY. Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-Hγ1 transgenic mice. J Immunol 1998; 161:49-59.
66. 66. Greenwald RJ, Lu P, Halvorson MJ, et al. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J Immunol 1997; 158:4088-96.
67. 67. Subramanian G, Katzura JW, Pearlman E, Jia X, Malhotra I, King CL. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 helper cell cytokine expression. J Immunol 1997; 158:5914-20.